| Source Date | Board Meeting Date | Details |
|
18-Jul-2025
|
25-Jul-2025
|
Quarterly Results
|
|
09-May-2025
|
22-May-2025
|
Audited Results & Dividend
|
|
23-Jan-2025
|
03-Feb-2025
|
Quarterly Results
|
|
11-Oct-2024
|
21-Oct-2024
|
Quarterly Results
|
|
12-Jul-2024
|
24-Jul-2024
|
Quarterly Results
|
|
19-Apr-2024
|
03-May-2024
|
Audited Results & Dividend
|
|
16-Jan-2024
|
01-Feb-2024
|
Quarterly Results (Revised)
|
|
11-Jan-2024
|
25-Jan-2024
|
Quarterly Results
|
|
10-Oct-2023
|
19-Oct-2023
|
Quarterly Results
|
|
14-Jul-2023
|
26-Jul-2023
|
Quarterly Results
|
|
02-May-2023
|
08-May-2023
|
Final Dividend (Revised) & Audited Results
|
|
27-Apr-2023
|
09-May-2023
|
Audited Results
|
|
11-Jan-2023
|
23-Jan-2023
|
Quarterly Results
|
|
10-Oct-2022
|
18-Oct-2022
|
Quarterly Results
|
|
29-Aug-2022
|
02-Sep-2022
|
Inter-alia, to consider and evaluate the proposals for fund raising by way of issue of equity shares/ preference shares/ bonds/ debentures/ non-convertible debt instruments/ warrants/ any other securities, including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combination thereof, subject to approval from the shareholders in the ensuing annual general meeting and sanctions/approvals from the other regulatory/ governmental authorities, as may be required.
|
|
13-Jul-2022
|
22-Jul-2022
|
Quarterly Results
|
|
13-Apr-2022
|
29-Apr-2022
|
Dividend & Audited Results
|
|
07-Jan-2022
|
17-Jan-2022
|
Quarterly Results
|
|
30-Sep-2021
|
11-Oct-2021
|
Quarterly Results
|
|
30-Aug-2021
|
03-Sep-2021
|
HFCL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2021 ,inter alia, to consider and approve inter-alia, to consider and evaluate the proposals for fund raising by way of issue of equity shares/ preference shares/ bonds/ debentures/ non-convertible debt instruments/ equity shares/ warrants/ any other securities, including through preferential issue on a private placement basis, qualified institutional placement, rights issue or any other methods or combination thereof, subject to approval from the shareholders in the ensuing annual general meeting and sanctions/approvals from the other regulatory/ overnmental authorities, as may be required.
|